Literature DB >> 31944849

Correlations of HIV Preexposure Prophylaxis Indications and Uptake, Chicago, Illinois, 2015-2018.

Maria Pyra1, Laura K Rusie1, Kristin Keglovitz Baker1, Andie Baker1, Jessica Ridgway1, John Schneider1.   

Abstract

Objectives. To examine gaps in identification of preexposure prophylaxis (PrEP) candidates, uptake, and use of PrEP by populations most likely to seroconvert.Methods. At a federally qualified health center in Chicago, Illinois, we used electronic medical records, prescription data, and our best approximation of Centers for Disease Control and Prevention PrEP guidelines to determine how many patients were indicated for PrEP relative to HIV diagnoses (indication:HIV), how many were on PrEP relative to indications (PrEP:indication), and how many were on PrEP relative to HIV diagnoses (PrEP:HIV). We compared these ratios across age, gender and orientation, race/ethnicity, and insurance.Results. Overall, there were 32 indications per incident diagnosis and 16 patients on PrEP per incident diagnosis. In adjusted models, Whites had higher indication:HIV and PrEP:HIV ratios compared with Blacks, men who have sex with men had higher indication:HIV and PrEP:HIV ratios compared with transwomen but lower PrEP:indication ratios, and uninsured patients had higher indication:HIV but lower PrEP:indication and PrEP:HIV ratios compared with those with insurance.Conclusions. PrEP use, relative to HIV diagnoses, differs by important patient characteristics. While improved guidelines will address some of the disparity, better approaches for determining PrEP candidates and more normalized patient-provider communication are needed to ensure better PrEP access to all individuals at high risk for HIV.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31944849      PMCID: PMC7002954          DOI: 10.2105/AJPH.2019.305469

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  26 in total

1.  Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States.

Authors:  Aaron J Siegler; Anna Bratcher; Kevin M Weiss; Farah Mouhanna; Lauren Ahlschlager; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-05-26       Impact factor: 3.797

2.  HIV Preexposure Prophylaxis as a Gateway to Primary Care.

Authors:  Julia L Marcus; Kenneth Levine; Chris Grasso; Douglas S Krakower; Victoria Powell; Kyle T Bernstein; Stephen Boswell; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2018-07-19       Impact factor: 9.308

3.  Amplifying the Population Health Benefits of PrEP for HIV Prevention.

Authors:  Jared M Baeten
Journal:  J Infect Dis       Date:  2018-04-23       Impact factor: 5.226

4.  Knowledge, Practices, and Barriers to HIV Preexposure Prophylaxis Prescribing Among Washington State Medical Providers.

Authors:  Brian R Wood; Vanessa M McMahan; Kelly Naismith; Jonathan B Stockton; Lori A Delaney; Joanne D Stekler
Journal:  Sex Transm Dis       Date:  2018-07       Impact factor: 2.830

5.  Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.

Authors:  Thomas H F Whitfield; Steven A John; H Jonathon Rendina; Christian Grov; Jeffrey T Parsons
Journal:  AIDS Behav       Date:  2018-11

6.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

7.  'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.

Authors:  Jae M Sevelius; JoAnne Keatley; Nikki Calma; Emily Arnold
Journal:  Glob Public Health       Date:  2016-03-10

8.  Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014.

Authors:  Brooke E Hoots; Teresa Finlayson; Lina Nerlander; Gabriela Paz-Bailey
Journal:  Clin Infect Dis       Date:  2016-06-09       Impact factor: 9.079

9.  Preexposure prophylaxis guidelines have low sensitivity for identifying seroconverters in a sample of young Black MSM in Chicago.

Authors:  Nicola Lancki; Ellen Almirol; Leigh Alon; Moira McNulty; John A Schneider
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

10.  Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.

Authors:  Sarah K Calabrese; Manya Magnus; Kenneth H Mayer; Douglas S Krakower; Adam I Eldahan; Lauren A Gaston Hawkins; Nathan B Hansen; Trace S Kershaw; Kristen Underhill; Joseph R Betancourt; John F Dovidio
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

View more
  4 in total

1.  Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.

Authors:  Maria Pyra; Russell Brewer; Laura Rusie; Jeanelle Kline; India Willis; John Schneider
Journal:  J Acquir Immune Defic Syndr       Date:  2022-02-01       Impact factor: 3.771

2.  Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.

Authors:  Afiba Manza-A Agovi; Ifedioranma Anikpo; Matthew J Cvitanovich; Esther O Fasanmi; Rohit P Ojha; Julia L Marcus
Journal:  J Acquir Immune Defic Syndr       Date:  2021-11-01       Impact factor: 3.771

3.  "I Just Decided to Stop:" Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya.

Authors:  Fernandos K Ongolly; Annabel Dolla; Kenneth Ngure; Elizabeth M Irungu; Josephine Odoyo; Elizabeth Wamoni; Kathryn Peebles; Kenneth Mugwanya; Nelly R Mugo; Elizabeth A Bukusi; Jennifer Morton; Jared M Baeten; Gabrielle O'Malley
Journal:  J Acquir Immune Defic Syndr       Date:  2021-05-01       Impact factor: 3.771

4.  "Now that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?" the condom quandary among PrEP users and health care providers in Kenya.

Authors:  Elizabeth M Irungu; Kenneth Ngure; Kenneth K Mugwanya; Merceline Awuor; Annabelle Dollah; Fernandos Ongolly; Nelly Mugo; Elizabeth Bukusi; Elizabeth Wamoni; Josephine Odoyo; Jennifer F Morton; Gena Barnabee; Irene Mukui; Jared M Baeten; Gabrielle O'Malley
Journal:  AIDS Care       Date:  2020-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.